In some cases, a patient who initially could be saved with tPA might not be saved ... enabling them to understand what causes a stroke and how different treatments work. This can fuel stroke ...

You may be familiar with the common signs and symptoms of a stroke: loss of vision, drooping face, weak limbs, and slurred ...

Patients with acute stroke benefit from thrombolysis ... treating patients who receive IV tPA with additional endovascular therapies. For now, endovascular treatment remains an important option ...

Additionally, this study reveals that the treatment used after a stroke, tPA, or Tissue Plasminogen Activator, also directly repairs any vasculature which was previously unknown. The study also ...

Blood clots are associated with life-threatening conditions such as sepsis, sickle cell disease, heart attack, and stroke.

A brain stroke occurs when blood flow to the brain is disrupted, depriving it of oxygen and nutrients. This leads to the rapid death of brain cells, causing severe health complications or even death.

Immediate treatment depends on the type of stroke. For ischemic strokes, clot-busting drugs like tPA (tissue plasminogen activator) can restore blood flow if administered within 3-4 hours.

UTHealth has a long tradition of stroke care innovation, having pioneered the use of tissue-type plasminogen activator (tPA), a life-saving treatment for acute ischaemic stroke, along with mobile ...

New research from Emory University may revolutionize how clinicians understand and treat these harmful blood clots, or thrombi, a byproduct of a condition called thromboinflammation. In a ...

The American Academy of Neurology and the American Heart Association have awarded the 2025 Ralph L. Sacco Scholarships for Brain Health to two researchers, Hortense Triniac, Ph.D., of Milwaukee and ...